Effect of initial treatment on health‐related quality of life in patients with newly diagnosed multiple myeloma without immediate stem cell transplant intent: results from the Connect(®) MM Registry

Although new multiple myeloma (MM) therapies are effective in alleviating some disease‐associated symptoms (e.g. bone pain, fatigue, functional decline), they can result in additional toxicities, further impacting health‐related quality of life (HRQoL). Here, we compared HRQoL and safety of lenalido...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Br J Haematol
Главные авторы: Abonour, Rafat, Rifkin, Robert M., Gasparetto, Cristina, Toomey, Kathleen, Durie, Brian G. M., Hardin, James W., Terebelo, Howard R., Jagannath, Sundar, Narang, Mohit, Ailawadhi, Sikander, Omel, James L., Lee, Hans C., Srinivasan, Shankar, Kitali, Amani, Agarwal, Amit, Wagner, Lynne
Формат: Artigo
Язык:Inglês
Опубликовано: John Wiley and Sons Inc. 2020
Предметы:
Haematological malignancy ‐ Clinical
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8048460/
https://ncbi.nlm.nih.gov/pubmed/33118614
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.17131
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы